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Abstract 
Objective: To explore how state legislatures and departments of health are responding to the 
public health and economic issues of increases in opioid use disorder and the impact on pregnant 
women and infants. 
Design: The design was a non-experimental descriptive study using a mixed methods survey 
research approach.   
Setting: Electronic and telephone survey of individuals from state departments of health 
associated with departments of behavioral health and substance use, or child and family services. 
Participants: Fifty-two respondents employed by individual state departments of health and 
child and family services.  
Methods: Univariate analysis and frequency distribution of ordinal variables was completed. 
Thematic analysis was used to analyze free text questions and identify themes. 
Results: All states reported recent changes or plans to address the problem of opioid misuse in 
their state. Many respondents feel their state continues to lack adequate services for treatment. 
Some states are exploring unique methods for addressing this in a safe and timely fashion, such 
as moving medication-assisted treatment to primary care and expanding licensure to Primary 
Care Physicians (PCPs) and nurse practitioners. 
Conclusions: Our findings demonstrate an increased commitment throughout the United States 
to enhance access to clinically appropriate treatment of substance use disorder particularly during 
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pregnancy, consider unique methods for addressing the problem of opioid dependency, and 
increase education and primary prevention programs.  
Key Words:  opioid use disorder, neonatal abstinence syndrome, maternal opioid use, health 
policy 
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Introduction 
Increasing mortality and morbidity associated with opioid misuse and abuse is a 
significant public health problem in the United States (US) and around the world. These 
concerns have been most urgently addressed in the United States, but opioid analgesic misuse 
and abuse in other countries was also highlighted by a Global Drug Survey in 2015 which 
included participants from the US, United Kingdom, France, Germany, and Australia (Morley, 
Ferris, Winstock, & Lynskey, 2017). Opioid misuse among women of child-bearing age and 
pregnant women presents unique and complex health concerns for the women and their children. 
Opioid misuse in this population has reached epidemic proportions in the US and has influenced 
maternal child health policy at the federal, state, and local levels. The number of women taking 
opioids during pregnancy increased five-fold between 2000 and 2009 (1.2 per 1000 live births to 
5.6 per 1000) (Patrick, Davis, Lehmann, & Cooper, 2015). Much of this increase was related to 
prescription opioid use and abuse. Between 1992 and 2012, the proportion of pregnant women 
admitted for treatment for substance use disorder that reported a history of prescription opioid 
misuse increased from 2% to 28% (Krans & Patrick, 2016). The rapid increase in the incidence 
of this problem, as well as the accompanying economic and societal costs, has attracted attention 
and research focus by many health care professionals and policymakers. It is essential that health 
care policy be informed by research and evidence-based guidelines which support optimal 
outcomes for both pregnant women and their infants. 
 
The purpose of this study was to examine current U.S. state policies and services related 
to treating opioid use during pregnancy and neonatal opioid withdrawal syndrome (NOWS), 
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specifically, how these policies have evolved recently related to the increased population of 
women of childbearing age with opioid use disorder and how well current policies align with the 
federal and state objectives for women and infants outlined in the Protecting Our Infants Act of 
2015 and in the National Governor’s Association (NGA) statement on Priorities for Addressing 
the Nation’s Opioid Crisis (NGA, 2016) . 
Through the Protecting Our Infants Act of 2015 (S.799/H.R.1462) (Congress, 2016), the 
federal government has described objectives for establishing and disseminating best practice 
strategies and recommendations for the diagnosis and treatment of infants who develop neonatal 
opioid withdrawal syndrome (NOWS) (White House, 2016). State priorities have been described 
by the National Governors Association (NGA) concerning prevention and treatment of OUD 
(Desai, Hernandez-Diaz, Bateman, & Huybrechts, 2014).  Private and public healthcare payers 
are also developing strategies to mitigate their costs and limit patient exposure to potentially 
addictive opioid medications (Katz et al., 2013).  
The recent NGA statement addresses opioid use and misuse as a public health crisis and 
describes states’ priorities. Priorities can include preventing and identifying addiction, 
developing best practice guidelines for addiction treatment services, increasing access to 
treatment programs, and eliminating regulations on Medicaid funding which restrict 
reimbursement for inpatient treatment for substance abuse and mental illness (NGA, 2016).   
Previous surveys have been conducted on this topic to assess state policies and practices 
concerning OUD in pregnancy. A survey of policies regarding substance use in pregnancy was 
conducted to assess the impact of decreased federal oversight and the transfer of budget and 
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regulatory control to the states which both occurred in 1994 (Chavkin, Breitbart, Elman, & Wise, 
1998). Their survey of state directors of addiction treatment services and child protective 
services showed an increase between 1992 and 1995 in mandatory drug testing of pregnant 
women and neonates (2% to 12%; .05% to 7%), increased mandatory reporting of positive 
maternal toxicology screens (2% to 17%), and an increase in criminal prosecution of women 
who used drugs (45% to 71%). There was also a trend toward mandating or prioritizing addiction 
treatment services for pregnant women (24% of states).  They found a general delay between the 
development of policy and the establishment of related services. There were gaps identified in 
policy, such as policy that mandated treatment didn’t address the lack of available treatment 
providers and whether they were eligible for reimbursement (Chavkin et al., 1998). This was the 
most comprehensive survey on the issues but was completed 20 years ago.  
The most recent survey of this type had a specific focus of examining state policies 
concerning mandatory reporting of substance use during pregnancy and it found twenty states 
had laws requiring health care providers to report perinatal substance use to child protective 
authorities, and four states required reporting only when a health care provider thought child 
maltreatment was involved. Only about 50% of states with a mandatory reporting law had a 
provision facilitating treatment for substance use disorder in the perinatal period (Jarlenski et al., 
2017). 
In 2004, a review was published summarizing policy research findings related to 
substance use during pregnancy (Lester, Andreozzi, & Appiah, 2004). Policy is usually shaped 
by elected officials within the context of social norms and public perception. There are two 
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competing discussions involving attitudes about maternal substance use which have shaped 
public perception and consequently informed policy. One discussion centered on the assertion 
that science defines substance use disorders as a mental health or medical illness. This leads to 
policies which emphasize treatment and prevention strategies. The competing approach centered 
on the premise that public safety is punitive and views pregnant women who misuse drugs as 
criminals who are placing their infants at risk. Proponents of both these approaches agree that a 
significant problem exists and should be addressed but disagree on many other points such as the 
appropriate clinical approach and availability of treatment, women’s autonomy, the legal status 
of the fetus, the formation of public health policy, and the usefulness of punitive measures. 
(Lester et al., 2004).  
This study will describe the impact of published federal and state objectives and 
professional organizations’ guidelines on current state programs and policies for pregnant 
women with OUD and infants with NOWS as perceived by personnel in addiction treatments 
services, departments of health, and child and family services from individual US states.  
Research Aims 
 Assess U.S. state legislatures current response to the public health and economic issue of 
increases in opioid use disorder (OUD) and its impact on pregnant women and infants as 
reported by survey respondents. 
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 Assess the impact of federal and state policy objectives (Protecting Our Infants Act of 
2015 and NGA priorities statement) and professional guidelines concerning OUD in pregnancy 
on public health and legislative initiatives as reported by survey respondents. 
Methods 
Sample   
Participants were a convenience sample of 145 representatives from multiple U.S. state 
departments of child welfare, child and family services, and divisions of mental health and 
addiction. The sampling frame and contact information was obtained from departmental contact 
listing from the Child Welfare Information Gateway, Substance Abuse and Mental Health 
Services Administration’s (SAMHSA) state profiles on substance abuse services, and individual 
states.gov websites and later by a respondent’s referral to the National Association of State 
Alcohol and Drug Abuse Directors. Participants were invited to participate by email contact with 
link to the electronic survey. They were initially contacted by email and were assured of 
confidentiality and given an opportunity to decline to participate in the study. The study was 
approved by the Institutional Review Board of the affiliated university. Identifiable data were 
stored securely in REDCap through a secured university account and password protected. Only 
coded or de-identified data were stored on portable devices.  
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Design and Materials 
The design was a non-experimental descriptive study using an electronic survey with 
telephone follow-up for non-respondents.  Study data were collected and managed using 
REDCap electronic data capture tools hosted at a large midwestern university (Harris PA, 2009). 
A 19-question survey instrument with a total of 54 discrete answers and two items with free text 
was developed (Appendix A). A pilot study to assess clarity and accessibility was conducted 
with five volunteer respondents who work in similar positions as the designated participants, 
within state child protective services or as health care social workers. The survey was revised to 
address any technical issues or ambiguity noted by the pilot volunteers.  
Procedure 
The survey link and a brief email introduction describing the goals of the survey and 
allowing participants to decline to participate by responding to the email (Appendix A) was sent 
to the selected agency representatives. The survey link remained open for two months, during 
which time reminders and telephone contacts were also being sent. No response to the email 
implied consent as stated in the letter. If no response was received within six weeks of the email 
with two reminder emails sent at two-week intervals, a telephone contact was attempted to offer 
the individual the opportunity to complete the survey via telephone conversation; in this way 
individuals with technical or user problems could still participate reducing potential nonresponse 
error. Early returns of the survey were scrutinized for any patterns of missed responses, skipped 
questions, or technical difficulties.
  
Corrections of these problems was addressed in follow-up 
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reminder surveys to avoid an unnecessary number of non-respondents or increased measurement 
error due to technical issues.  
The initial survey was sent with a unique individual identifier and could not be forwarded 
to closely control and identify respondents. This proved too cumbersome for respondents, as it 
required contacting the study team by email or telephone to refer the survey to co-workers who 
they felt could provide more complete information. In subsequent electronic mailings, a public 
link was included and allowed recipients to forward the survey.  
Responses to surveys completed online were downloaded into an electronic database 
spreadsheet (Excel) per REDCap©. Responses to surveys conducted by telephone were manually 
entered into the database. Out of a total of 145 survey invitations sent electronically, 52 (36%) 
responses were received either online (33) or by telephone (19).  The 52 respondents represented 
42 different states (84% of US states). Eight states had two respondents and one state had three 
respondents. Two question responses from one state were dropped due to conflicts in answers 
from multiple participants from the state. The states participating are listed in Table 1. 
Participating States  
Table 1  
Northeast South Midwest West 
Connecticut Alabama  Illinois Alaska 
Maine Arkansas Indiana California 
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 Maryland Florida Iowa Colorado  
 Massachusetts Georgia Kansas Hawaii 
 New Hampshire Louisiana Minnesota Idaho  
  Pennsylvania Mississippi Missouri  Montana 
 Vermont North Carolina Nebraska   Nevada 
  South Carolina North Dakota   New Mexico 
 Tennessee Ohio   Oregon 
 Texas South Dakota  Utah 
 Virginia Wisconsin  Washington 
 West Virginia  Wyoming 
 
ata analysis 
The data were first reviewed to find and delete incomplete and duplicate responses. The 
two open-ended questions were analyzed with a qualitative descriptive approach. The researcher 
conducted a thematic analysis (Sandelowski, 2010; Vaismoradi, 2013) of the two items requiring 
free text. Coding and thematic analysis were conducted using the thematic analysis process 
described by Vaismoradi (2013). The data analysis consisted of organizing data, including 
generating initial codes, searching for themes, and reviewing and naming themes (Table 3). 
Descriptive statistics and relative frequency statistics were calculated on the ordinal data using 
REDCap© and the SPSS statistical package (IBM 2016). 
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Results 
Respondents’ Information and Demographics 
Responses received were evenly split between agencies.  Of the 52 respondents, 31% 
came from children and family services staff and 46% from behavioral health/ substance use/ 
addiction services staff.  Twenty-three percent were from other divisions which included public 
education and communication. Professional credentials were not captured for 29% of 
respondents (online respondents without possibility of follow up). Of those respondents who 
indicated their professional credentials, social workers and nurses both comprised 13.5% of 
respondents, 6% were physicians, and psychologists were 2%. Many respondents in the 
telephone interviews indicated a professional role in public communication or community 
education (37%). Nearly half of respondents reported 5 or more years of experience in their 
position (48%), nearly one-quarter had 3-4 years of experience (23%), and slightly more than 
one quarter had 2 or fewer years’ experience (29%). A summary of respondents’ information can 
be found in Table 2. 
Respondents Demographic Information 
Table 2 
Respondents N=52 N % 
Agency/Division   
     Child and Family Services 16 31 
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     Substance Abuse/Addiction  24 46 
     Other 12 23 
Professional Credentials   
     Social Worker 7 13.5 
     Nurse 7 13.5 
     Physician 3 6 
     Psychologist 1 2 
     Communication/Education 19 37 
     Other 15 29 
Years of Experience   
     <1 year 1 2 
     1-2 years 8 27 
     3-4 years 12 23 
     5 or more years 25 48 
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Research Aim One: Assess U.S. State Legislatures’ Response to Increases in Opioid Use 
Disorder 
Screening and Services 
Respondents from all participating states indicated they were responding in some way to 
the public health and economic impact of increases in OUD. These actions included a 
combination of public health initiatives, surveillance, and clinical treatment. Thirty-one percent 
of states (13) represented indicated screening of either mothers or infants, or both was required in 
their state. Nine states indicated mandatory screening for both mother and infant, two for 
mothers only, and two for infants only. Forty-three per cent of the states (18) responding 
indicated their state required mandatory reporting of a positive screen in pregnant women to 
child protective services. Sixty-four percent (31) indicated their state required mandatory 
reporting of positive screens in newborn infants to child protective services and one state (2%) 
required reporting to the state department of health. No states required reporting to law 
enforcement. A positive maternal or infant toxicology screen was categorized as child abuse or 
neglect in 38% (16) of the states. Twenty-three percent of the states (10) indicated their state has 
criminally prosecuted women for using illicit drugs during pregnancy at some time, 76% (32) 
indicated their state never utilizes criminal prosecution for abuse, neglect or other charges. 
No state responded that enrollment in treatment services was always mandatory for 
women with positive toxicology screens during pregnancy. Treatment enrollment was required 
most of the time in 10% of states responding (4 of 41) and some of the time in 32% (13). Of 
those states responding, 58% (24) replied that treatment was never mandatory. Only 5% (2 of 40) 
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states felt availability of treatment services was always adequate in their state, 25% (10) 
responded there were adequate treatment services available most of the time, 52% (21) felt 
service availability was sometimes adequate, and 18% (7) reported that services were never 
adequate.  
Medicaid coverage for the expense of opioid dependence treatment was reported as 
always available by 23 of 41 states (one states did not report) for 56% of states, 24% (10) 
reported it was available most of the time, and 20% (8) reported it was available some of the 
time. Some additional services for pregnant women with opioid dependence were offered in 98% 
(41 of 42 reporting) of states. Only one state reported their state never offered additional services 
or prioritized pregnant women for opioid dependence programs. Forty-five percent (19) reported 
additional services were available some of the time, 17% (7) most of the time, and 36% (15) said 
they were always available. Additional strategies to facilitate participation which were reported 
included prioritizing pregnant women with SUD for available treatment, waiving fees and co-
pays, providing social support services including transportation and childcare, and coordinating 
services which combined prenatal care, behavioral health, and treatment for opioid dependence. 
Routine developmental follow up for infants exposed to opioids during pregnancy was 
provided by 36% (15) of the 42 states some of the time and 43% (18) most of the time.  Fourteen 
percent of states (6) said they always provide routine developmental follow up while 7% (3) 
reported that they never provide developmental services. Thirty-one of 42 states (74%) had 
recently either passed legislation or increased funding related to opioid dependence. Most states, 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
 
16 
 
27 of 42 or 64%, reported plans to increase funding or programs related to opioid use. The 
results of the multiple-choice responses are also summarized in Table 3. 
Table 3  
Summary of Multiple-Choice Question Responses by State 
Question: All the 
Time 
Most of 
the 
Time 
Some of 
the Time 
Never 
Does your state criminally prosecute mothers 
 for illicit drug use during pregnancy? 
 
    0%   0%   
 
  23% 
(n=10) *          
  77% 
(n=32)          
 
Is the availability of addiction treatment 
 services adequate in your state? 
 
5% 
(n=2) 
25% 
(n=10) 
52% 
(n=22) 
18% 
(n=8) 
In your state, is participation in treatment 
 mandatory in cases of positive toxicology 
 screen during pregnancy? 
 
0% 10% 
(n=4) 
32% 
(n=13) 
58% 
(n=24) 
Does your state provide Medicaid coverage 
 for opioid use disorder (OUD) treatment? 
 
55% 
(n=23) 
24% 
(n=10) 
21% 
(n=9) 
0% 
Does your state offer additional services 
 which facilitate OUD treatment during pregnancy? 
 
36% 
(n=15) 
17% 
(n=7) 
45% 
(n=19) 
2% 
(n=1) 
Does your state provide developmental follow up 
 services for infants exposed to opioid during 
14% 
(n=6) 
43% 
(n=18) 
36% 
(n=16) 
7% 
(n=3) 
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pregnancy? 
 
Does your state require universal toxicology 
screening? 
 Yes   No   
For Mothers 30% 
(n=13) 
70% 
(n=29) 
  
For Infants 
 
30% 
(n=13) 
70% 
(n=29) 
  
Does your state require mandatory reporting of  
positive infant toxicology screens?  
    
Child Protective Services 
 
64% 
(n=27) 
36% 
(n=15) 
  
Department of Health 2% 
(n=1) 
98% 
(n=41) 
  
Is a positive maternal toxicology screen 
considered abuse or neglect? 
 
38% 
(n=16) 
 
62% 
(n=26) 
  
Has your state recently passed legislation or 
increased funding of programs for OUD? 
 
74% 
(n=31) 
26% 
(n=11) 
  
Does your state have plans to increase funding for 
programs for OUD treatment in the future? 
64% 
(n=27) 
12% 
(n=5) 
Unsure 
24% 
(n=10)  
 
 
*n = number of states (52 total respondents 
representing 42 states) 
    
Research Aim Two: Assessing the Impact of Federal and State Policy Objectives and 
Professional Guidelines on States’ Response 
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Eighty per cent of states (34) who participated in the survey had recently passed laws to 
increase funding, or added programs and services related to opioid use.  Plans to increase 
funding or programs were also common among the states participating with 64% (n=27) 
answering yes, 12% (n=5) responding no, and 24% (n=10) unsure of plans. Respondents from 32 
of the 42 (76%) states participating described recent increases in funding or programs and plans 
for increasing funding or additional programs in the free text portion of the survey.  
In the qualitative portion of the analysis, seven themes were identified in the narrative 
responses: Increased availability of medication assisted treatment (28 of 32), Education and 
regulation of safe prescribing practices (5), Increased availability of naloxone (7), Increasing 
services in rural areas (13), Increased availability of services for pregnant women & families 
(9), Increased funding & reimbursement for treatment services both outpatient and residential 
(17), and Plans for education and prevention programs (12). A summary of the themes identified 
in the narrative responses with participant quotations can be found in Table 3. 
The exact impact of federal and state policies (i.e. Protecting Our Infants Act of 2015 and 
NGA priorities statement) and guidelines developed by professional organizations (ACOG, 
AAP) designed to influence the incidence and severity of maternal opioid use and NOWS on 
public health and legislative initiatives at the state level is difficult to assess from the responses 
to the survey. There are many instances in the states participating in the survey where recent 
state policy changes and plans align with recommendations from these documents.  Points 
identifiable include developing guidance of best practice to treat NOWS, adoption of the 
effective evidence-based guidelines for care of pregnant women with opioid use disorder and 
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decreasing the likelihood of illicit prenatal opioid exposure by improving screening for OUD and 
increasing access to treatment interventions that prevent misuse of opioids by women of 
childbearing age (SAMHSA, 2017). It is difficult to determine from the respondents’ comments 
if objectives such as treating both the mother and the infant and providing accessible family 
friendly services for pregnant and parenting women with OUD and their infants are included in 
current services or plans. 
Comments on recent changes included descriptions of programs aimed at the states’ 
general population, as well as some programs which specifically targeted pregnant women and 
infants. One participant stated, “funding was not directly impacting pregnant women but does not 
exclude them either.” Focus areas for treatment for the general population included additional 
funding for medication assisted treatment services, expanded Medicaid coverage for treatment 
services, and liberalizing licensure practices for OUD treatment programs. Other recent changes 
included establishing care coordination positions within the state and counties, expanded services 
to rural areas through primary care engagement in treatment, additional oversight and tracking of 
prescribing practices, and increased availability of naloxone for overdose treatment. Increasing 
education and prevention efforts was also described in response to recent changes in programs or 
funding, including education to providers on appropriate opioid prescribing and public education 
on safe use of opioids and early identification of opioid misuse. 
Specifically, for women and children, recent enhancement of programs included 
increasing targeted outreach programs to engage women earlier in care, expansion of high-risk 
pregnancy services to include opioid dependence, and increasing availability of opioid use 
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disorder treatment and behavioral health services within prenatal care. Some states also reported 
establishing care coordination services for pregnant women to include treatment for opioid 
dependence and behavioral health services, and implementing specialized programs targeted for 
pregnant women and families designed to reduce the severity of neonatal opioid withdrawal 
syndrome, such as additional education and clinical care guidelines for obstetric and pediatric 
care providers, embedding opioid use disorder treatment within primary and obstetric services, 
and prenatal education for mothers on opioid effects on infants and expected care after delivery. 
Comments related to plans included comments to continue to enhance, expand, and 
integrate recovery support and services. Some participants who offered specific comments 
mentioned increased access to naloxone, increased funding for medication assisted treatment, 
expanding to primary care-based programs with family physicians and advanced practice nurses 
in rural areas, expanding residential services, and enhancing community-based recovery support. 
Two respondents mentioned their future planning is dependent on the future of the patient 
protection and affordable care act (ACA) which will determine available funding for OUD both 
at the federal and state level. Other common areas mentioned in plans to increase funding or 
programs in the future were initiatives for primary prevention, early intervention, and public 
health education.  
Table 4 
Qualitative Analysis: Current and Future Plans for Treatment of Opioid Use 
Disorder 
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Themes Representative Quotes 
Increased 
availability of 
medication 
assisted 
treatment 
Allows all medication approved by FDA to be used in licensed 
narcotic treatment programs 
More liberal licensing for suboxone providers (PCP) 
Expansion of the number of OTPs and OBOTs with tripling of 
number of people in treatment  
 
Education and 
regulation of 
safe 
prescribing 
practices 
 
Recent laws passed affect prescription of opioids 
Clinical practice measures for safer opioid prescribing 
Prescription monitoring and electronic tracking of opioid 
prescribing patterns 
Increased 
availability of 
naloxone 
 
Naloxone standing orders 
Increased Narcan availability to the pubic 
 
Increasing 
services in 
rural areas 
Pilot of expansion of MAT services in rural areas using advanced 
practice nurses 
Through grant funding office-based narcotic treatment programs 
will be available in rural (state) 
…looking at recruiting MAT providers in rural areas 
 
Increased 
availability of 
services for 
pregnant 
women & 
families 
Increasing targeted outreach services to engage women earlier in 
care 
Increasing the availability of intervention and treatment services for 
pregnant women 
Development of NAS peer recovery support specialists 
Addition of Family Task Force 
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Pilot treatment programs for mothers with children 
Developed clinical guidelines to assist providers in care of pregnant 
women and infants 
Private grant funded program offering addtl assistance to pregnant 
women such as transportation, child care, and durable good 
 
Increased 
funding & 
reimbursement 
for treatment 
services 
outpatient and 
residential  
Obtained additional federal funds for medication assisted treatment 
Additional funding related to opioid treatment 
Increase in funding for all SUD services 
Funding for and certification of recovery housing 
Approval of Medicaid waiver to pay for residential services 
Include coverage for adult residential and partial hospitalization 
programs 
 
Plans for 
education and 
prevention 
programs 
Increase education and prevention efforts 
Implement programs for the prevention … of opioid misuse 
Enhance prevention education focusing on parents and adolescents 
Statewide public awareness campaign 
Discussion 
These findings capture a particular moment when there is heightened attention by the 
public and by policymakers on the public health issue of opioid misuse (Blendon, McMurtry, 
Benson, & Sayde, 2016; Blendon & Benson, 2018). The survey reflects US states are universally 
recognizing the need for additional services and funding in the area of opioid use and 
dependence. All respondents indicate either recent changes, or plans to make changes in funding, 
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education, surveillance, and availability of services. Opinion and policy in this area are rapidly 
evolving making it difficult to precisely track the changes. One respondent simply replied to the 
question about recent changes, “unable to name all our recent changes.”  
Many of the states surveyed reported recent changes which were directed at early 
identification and facilitating entry into treatment however states also reported their state lacks 
adequate services for referral to treatment once substance abuse has been identified. Many states 
indicate they are examining unique methods for addressing this in a safe and timely fashion, such 
as moving medication-assisted treatment to primary care and expanding licensure to PCPs and 
nurse practitioners. Several states reported public education about safe opioid use and primary 
prevention as priorities in their plans to increase programs or funding.  
Medical evidence support substance use disorder is a chronic and treatable disease, but 
public opinion continues to be mixed with conflicts apparent in some policies which reflect the 
continued view of substance use as a moral issue (Angelotta, Weiss, Angelotta, & Friedman, 
2016; McGinty et al., 2015). Evidence of these attitudes is apparent in our survey results with 10 
states (24%) indicating prosecution of maternal substance abuse is sometimes pursued. These 
punitive responses continue in some areas even though they have been shown to be costly and 
ineffective (Kovac, 2013; Paltrow & Flavin, 2013). This attitude may be driven by policymakers’ 
constituents who sometimes continue to see substance abuse as a criminal and moral issue, rather 
than as a chronic disease (Blendon & Benson, 2018; Stone, 2015). Results of a study analyzing 
media coverage of opioid misuse indicated the issue is most often presented as a criminal justice 
issue mentioning illegal drug trafficking and law enforcement solutions (McGinty et al., 2015) 
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which may contribute to the continued discussion of punitive responses.  However, it is 
encouraging that the program responses described by the states included in this survey indicate 
policy and program changes in recent years and their future plans emphasize a public health 
approach, addressing issues with safety such increased naloxone availability, screening to 
identify those in need of treatment and a focus on increasing (Blendon et al., 2016) availability 
and funding of effective treatment. There were no comments related to increasing criminal 
justice approach and the only mention of law enforcement was in the theme of education. 
Previous research in this area indicated, state policy around perinatal substance misuse 
was shaped through two objectives; the state has a concern for the welfare of its citizens, and 
then the overall cost to the state (medical care, child protective services, public assistance and 
foster care are some of the state budget areas impacted by OUD in pregnancy) (Bishop et al., 
2017). State approaches included prosecutorial strategies with a variety of potential charges for 
pregnant women who use substances (child abuse, delivery of controlled substances to a minor, 
manslaughter) (Flavin & Paltrow, 2010). At the time of a prior review, three states mandated 
universal screening of pregnant women for substance use, fifteen (30%) mandated reporting 
prenatal substance misuse as child abuse and more than 25% of states (13) had passed laws that 
defined maternal substance use as child abuse (Lester et al., 2004). Fifteen states provided 
treatment programs for substance use disorder or coordination of services of prenatal care and 
substance use disorder, and four states gave priority access for addiction treatment services to 
pregnant women (Lester et al., 2004).  
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Plans for programs and funding also need to continue to address outdated and 
stigmatizing beliefs as they inhibit both individuals with SUD and the public from effectively 
responding to the epidemic. For individuals with SUD, marginalization resulting from continued 
social stigma associated with substance use inhibits their help-seeking behavior and limits access 
to and use of harm reduction and treatment and recovery resources. For public health policy, 
outdated and stigmatizing beliefs will continue to interfere with the development and funding of 
innovative and effective substance use prevention and treatment programs. Implementation of 
evidence-based public health-oriented approaches are essential for progress toward the state and 
federal goals of reducing OUD and its consequences.  
Limitations 
There are several limitations to this study, the first of which is the representativeness of 
the sample. Self-directed sampling was utilized, soliciting representatives assigned as state 
contacts on the online SAMHSA and the Child Welfare Gateway directories who the researchers 
felt might increase the likelihood they were interested and informed on substance misuse, 
perinatal substance use, and NOWS. Choosing potential participants from a public list presents 
several problems: the contact list may not be accurate and up to date, and the recipient may not 
be familiar with the topic areas. The demographic information was limited because the survey 
did not allow a free text answer for the question concerning professional credentials. Many of 
our respondents recorded “other”. The telephone respondents in the “other” category indicated 
their roles were in, case management or communication/public relations, but the online survey 
was not constructed to obtain complete information in this area. 
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The decision to provide a public link and permit forwarding increased the number of 
respondents.  The public link was forwarded a total of 39 times and resulted in thirteen additional 
electronic surveys returned, unlike the invited participants, in this group identifying and 
demographic information were completed entirely by self-report and accuracy cannot be verified.  
The state field was completed in all the surveys completed by public link, but email address and 
name, which was available for the invited surveys, was not collected. Response bias is always a 
concern for survey research and there may be respondents who viewed their state response to 
OUD in either an overly positive or negative way. Respondents also may not feel comfortable 
providing answers that present themselves, or their state, in an unfavorable manner. 
The survey was sent to two or three representatives from each state to increase the 
likelihood of obtaining information from a high percentage of states. More than one response 
was received from some states and in some instances different answers were recorded from the 
same state. In two instances, one respondent had left a question blank and another had answered. 
In these cases, the answers were used in the analysis. Three respondents from the same state had 
conflicting answers on multiple-choice questions and their responses to those question were 
dropped from the analysis. The ability to reach respondents is one challenge of surveys. 
Technical difficulties which may limit access to the online survey is a potential threat.  There 
was a significant technical issue with one electronic follow up mailing preventing the personal 
link from working correctly, and some participants could not access the survey. The researcher 
was notified, and the issue corrected, but this technical issue may have discouraged and 
frustrated some potential respondents. 
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Some of the survey response options may have been unclear, leading to variations in 
interpretation and responses. For example, the response option “some of the time” may represent 
different amounts to different respondents.  There were also respondents who requested a 
response of “not applicable”, although we had purposely not included this as an option as we felt 
it was not an appropriate answer. However, another available option such as “unsure”, or “I do 
not know” may have been an accurate alternative option. 
The survey represents a very limited snapshot of the OUD epidemic. OUD is a public 
health emergency which is currently receiving tremendous attention by public health officials, 
policymakers, and the public. Policies and practices are very fluid and are evolving regularly. 
There may have been significant changes in policies and services, even during the relatively brief 
time it took to collect and analyze this data.  There is also a predictable lag between development 
of policy and the offering of program services, so responses concerning plans or policy may not 
reflect actual availability of services. 
Conclusions 
Numerous initiatives have been undertaken at the federal and state level to address opioid 
use and dependency (Krans & Patrick, 2016; Madras, 2017). Overwhelmingly, states have 
recently initiated programs and the majority continue to plan for additional programs.  The 
responses indicate most states have enacted changes such as expanding services, increasing 
reimbursement, prioritizing evidence-based care with development of clinical guidelines, and 
increasing availability of treatment for the general population with OUD. The responses did not 
indicate recent changes or future plans which specifically addressed gender-related issues for 
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women with OUD, such as responsibility for children, increased need for social support and 
services and greater incidence of comorbidities such as behavioral health issues (Greenfield et 
al., 2007). However, most states who participated in the survey indicated they have prioritized or 
expanded services for pregnant women and infants or have plans to do so in the future. There are 
important state level disparities in screening, reporting, availability of treatment, Medicaid 
coverage for treatment, and available developmental follow up for infants. Although decreased in 
numbers from past surveys cited in the literature review there are still some states continuing to 
pursue outdated and stigmatizing policies of criminal prosecution which is an important area to 
address in future planning through education of the public and reframing of media coverage of 
the opioid misuse issue.  Global research indicates misuse and abuse of opioids is a problem that 
is not limited to the United States and may warrant attention and cooperation on an international 
scale (Morley et al., 2017). Approaches to the prevention and treatment of maternal OUD and 
NOWS will develop rapidly in the current climate and remaining up-to-date will continue to be a 
challenge.  
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Highlights 
 All states surveyed reported recent changes or plans to address the problem of opioid 
misuse in their state.  
 Many respondents felt their state continues to lack adequate services for opioid addiction 
treatment.  
 Some states are exploring unique methods for addressing this in a safe and timely 
fashion, such as moving medication-assisted treatment to primary care and expanding 
licensure to Primary Care Physicians (PCPs) and nurse practitioners. 
 Findings demonstrate an increased commitment throughout the United States to enhance 
access to clinically appropriate treatment of substance use disorder particularly during 
pregnancy, consider unique methods for addressing the problem of opioid dependency, 
and increasing education and primary prevention programs. 
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